IPSEY - Ipsen secures exclusive global rights of Sutro Biopharma's STRO-003 ADC
2024-04-02 04:03:00 ET
Ipsen ( OTCPK:IPSEY ) has secured exclusive global rights for the development and commercialization of STRO-003, an antibody-drug conjugate, from Sutro Biopharma ( NASDAQ: STRO ), completing the final stages of pre-clinical development, the companies said on Tuesday....
Ipsen secures exclusive global rights of Sutro Biopharma's STRO-003 ADC